Medical Health Cluster

Omicron

How Will the Pandemic Evolve After the Omicron Variant?

France — During a round-table discussion at the French Senate, specialists in infectious disease and epidemiology presented their thoughts on what might happen after the Omicron wave passes. Will COVID become an endemic disease, or will new, worrisome variants emerge? Using various types of data, the experts shared their views which, […]

Read More

Double-Dose COVID-19 Vaccines Showed Limited Effectiveness Against Omicron

The currently available two-dose COVID-19 vaccines were not effective in preventing symptomatic disease caused by the Omicron variant, as determined on the basis of data from more than 800,000 Omicron-infected individuals. Early laboratory data suggested a substantially lower neutralizing antibody response to the Omicron variant compared to both the original […]

Read More

Covid-19 Vaccine Effectiveness
against the Omicron (B.1.1.529) Variant

BACKGROUND A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused concerns about the effectiveness of current vaccines. METHODS We used a test-negative case–control design to estimate vaccine effectiveness against symptomatic disease […]

Read More

Subvariante Ómicron: conoce qué es la lengua COVID y cómo detectarla

Desde su aparición a fines de 2019 hasta la fecha, el coronavirus ha afectado a una gran parte del mundo. Una gama de síntomas que varía de persona a persona, una fase de COVID prolongada o posterior a COVID y muchas otras gravedades están asociadas con la infección viral, entre […]

Read More

Estimated 73% of US now immune to omicron: Is that enough?

The omicron wave that assaulted the United States this winter also bolstered its defenses, leaving enough protection against the coronavirus that future spikes will likely require much less — if any — dramatic disruption to society. Millions of individual Americans’ immune systems now recognize the virus and are primed to fight it […]

Read More

COVID-19 vaccines induce immune response to Omicron

Viruses constantly evolve over time through mutations. This can result in new variants, like the fast-spreading Omicron variant of SARS-CoV-2. Omicron has a large number of mutations in its spike protein, which makes it more able to latch onto and infect cells. As a result, Omicron spreads more easily and causes […]

Read More

Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022

What is already known about this topic? CDC conducts genomic surveillance to track SARS-CoV-2 variants in the United States. What is added by this report? CDC’s SARS-CoV-2 genomic surveillance has been expanded to incorporate sequence data from public repositories and to produce weighted estimates of variant proportions at the jurisdiction […]

Read More

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody

The SARS-CoV-2 Omicron variant has become the dominant infective strain. We report the structures of the Omicron spike trimer on its own or in complex with ACE2 or an anti-Omicron antibody. Most Omicron mutations are located on the surface of the spike protein, which change binding epitopes to many current […]

Read More

Subvariante BA.2 de ómicron: lo que sabemos hasta ahora

Los datos más recientes de la Agencia de Seguridad Sanitaria del Reino Unido (UKHSA) sugieren que la subvariante BA.2, un linaje descendiente de la variante B.1.1.529, puede ser incluso más transmisible que la variante original.[1] Pero la buena noticia es que las vacunas actuales parecen ofrecer el mismo nivel de protección contra […]

Read More